Full-Time

Chief Medical Safety Officer; VP

Clinical Oversight & Innovation

Confirmed live in the last 24 hours

iRhythm Technologies

iRhythm Technologies

1,001-5,000 employees

Advanced cardiac monitoring solutions provider

Biotechnology
Healthcare

Compensation Overview

$287.9k - $429.2kAnnually

Senior, Expert

Remote in USA

Category
Physicians & Surgeons
Medical, Clinical & Veterinary
Required Skills
Data Science
Product Management
Requirements
  • MD or equivalent medical degree with subspecialty board certification in cardiac electrophysiology or cardiology. Ongoing or recent medical practice is strongly preferred.
  • Active medical license
  • Minimum 15 years combined years of experience in clinical practice, academic medicine, and medical device industry, with a focus on cardiovascular diagnostics and digital health
  • Strong understanding of FDA regulations and regulated products in cardiovascular disease including hardware, software as medical device, and AI technologies
  • Experience in ambulatory ECG IDTF operations and clinical workflow of ambulatory cardiac monitoring
  • Expertise in AI and machine learning applications in healthcare
  • Proven track record in implementing medical safety programs and driving clinical innovation, with a demonstrated ability to lead change.
  • Strong leadership and management experience with a track record of influencing all levels in medium to large organizations.
  • Excellent leadership, communication, and strategic thinking skills.
Responsibilities
  • Ensure comprehensive medical safety governance from product design to post-market surveillance. Working closely with the VP of Quality, will oversee adverse event monitoring, analysis, and safety reporting. Collaborate with Quality Affairs and Regulatory Affairs to ensure compliance with regulations and industry standards.
  • Serve as the senior medical director of the IDTF, providing clinical supervision and oversight of ambulatory cardiac monitoring services, including long-term continuous monitoring and mobile cardiac telemetry, and of the site-based IDTF directors, who will report to the individual. Ensure compliance with all regulatory, payer, and clinical requirements for IDTFs, including supervision of diagnostic tests and quality control measures in partnership with the Senior Vice President of Clinical Operations.
  • Provide medical expertise and guidance throughout the product lifecycle (design, clearance, commercialization, post-market surveillance, lifecycle management). Participate in pre-submission meetings with regulatory bodies and contribute to regulatory submissions. Collaborate with Product Management, Product Development, and Systems Development to provide medical input on new product development and enhancements. Serve as a final approver, shared with the CMO, of all clinical and medical decisions touching product, service, labeling, and related organizational functions.
  • Support the Scientific Affairs function to guide real-world evidence studies and clinical research initiatives. Contribute to the design and interpretation of observational data, clinical trials, data science, and new product innovation studies, functioning as an internal principal or collaborating investigator. Represent the company at scientific conferences and engage with key opinion leaders in the field of cardiology and digital health.
  • Along with the CMO, work closely with Medical Affairs, Commercial, Product Marketing, Corporate Strategy, Regulatory Affairs, Quality Affairs, and other teams to fully integrate medical perspectives. Work with Medical Affairs and Sales Enablement for clinical knowledge dissemination, development of medical claims, and creation of digital content. Serve as a medical liaison between the company and external stakeholders, including healthcare providers, regulatory agencies, and industry partners.

iRhythm Technologies focuses on cardiac monitoring solutions, with its main product being the Zio Patch, a wearable device that tracks heart rhythms for up to 14 days. This extended monitoring helps healthcare providers detect irregular heart rhythms that may be missed with shorter tests. The Zio Patch is beneficial for patients who suspect heart issues, allowing them to monitor their heart activity without frequent office visits, which is especially important during the telehealth era. iRhythm differentiates itself by providing comprehensive data analysis services alongside the device, enhancing diagnostic capabilities for healthcare providers.

Company Stage

IPO

Total Funding

$102.8M

Headquarters

San Francisco, California

Founded

2006

Growth & Insights
Headcount

6 month growth

5%

1 year growth

7%

2 year growth

23%
Simplify Jobs

Simplify's Take

What believers are saying

  • Recent investments from Daiwa Securities and Capstone Investment Advisors indicate strong market confidence in iRhythm's growth potential.
  • The expansion into international markets and new initiatives like the 'Know Your Rhythm' campaign could drive significant revenue growth.
  • Collaborations with major healthcare platforms like Epic enhance iRhythm's market penetration and operational efficiency.

What critics are saying

  • Ongoing class action lawsuits could result in substantial financial liabilities and damage to iRhythm's reputation.
  • The competitive landscape in cardiac monitoring is intense, requiring continuous innovation to maintain market leadership.

What makes iRhythm Technologies unique

  • iRhythm's Zio Patch offers up to 14 days of continuous cardiac monitoring, significantly longer than many competitors' devices.
  • The integration with Epic allows seamless data sharing and workflow integration for healthcare providers, enhancing diagnostic efficiency.
  • iRhythm's focus on telehealth solutions positions it well in the evolving healthcare landscape, especially post-COVID-19.

Help us improve and share your feedback! Did you find this helpful?